Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

BACKGROUND: Oral mucositis is a common inflammatory complication in patients undergoing high-dose chemotherapy and radiation followed by haematopoietic stem cell transplantation (HSCT). Lactobacillus brevis CD2 has been proven efficacious in preventing chemoradiotherapy-induced oral mucositis in squ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESMO Open
Main Authors: Sharma, Atul, Tilak, TVSVGK, Bakhshi, Sameer, Raina, Vinod, Kumar, Lalit, Chaudhary, Surendra Pal, Sahoo, Ranjit Kumar, Gupta, Ritu, Thulkar, Sanjay
Formato: Artigo
Idioma:Inglês
Publicado em: ESMO Open 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548970/
https://ncbi.nlm.nih.gov/pubmed/28848667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados